Total planned funding: $212,925,446
Allocations
Countries/Regions
| Eswatini | $212,925,446 |
Organizational Types
| Private Contractor | $52,754,898 |
| NGO | $47,550,039 |
| Unknown | $38,281,508 |
| University | $34,137,151 |
| Own Agency | $24,522,184 |
| Multi-lateral Agency | $6,406,214 |
| Host Country Government Agency | $4,783,060 |
| Other USG Agency | $3,671,061 |
| FBO | $742,500 |
| Implementing Agency | $76,831 |
Program Areas
| Care | $62,889,662 |
| Treatment | $52,863,762 |
| Prevention | $40,317,465 |
| Governance and Systems | $29,742,472 |
| Management and Operations | $13,849,061 |
| Testing | $13,263,024 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $38,458,603 |
| HBHC: Care: Adult Care and Support | $25,695,142 |
| HKID: Care: Orphans and Vulnerable Children | $17,897,597 |
| HVSI: Strategic Information | $17,709,907 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $13,970,750 |
| HVMS: Management and Operations | $13,849,061 |
| HVTB: Care: TB/HIV | $13,400,047 |
| HVCT: Testing: HIV Testing and Counseling | $13,263,024 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $11,020,048 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,267,601 |
| HTXD: Treatment: ARV Drugs | $10,140,388 |
| OHSS: Health Systems Strengthening | $7,862,695 |
| PDCS: Care: Pediatric Care and Support | $5,896,876 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,512,066 |
| PDTX: Treatment: Pediatric Treatment | $4,264,771 |
| HLAB: Laboratory Infrastructure | $4,169,870 |
| HMBL: Biomedical Prevention: Blood Safety | $547,000 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$38,131,508
Countries/Regions
Columbia University:
$28,476,453
Countries/Regions
Pact, Inc.:
$21,574,046
Countries/Regions
USG Aggregated Agencies:
$17,324,661
Countries/Regions